Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors ...

Revolution Medicines' promising KRAS inhibitors show potential in pancreatic cancer. See why we recommend a hold rating on ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

Agenus (AGEN) presented multiple posters and presentations for botensilimab and balstilimab across various treatment lines of colon and ...

Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Oral paclitaxel matched IV in progression-free survival but outperformed it in overall survival for second-line advanced ...

E ARS The Rooks County Conservation District’s 77th Annual Meeting will take place on Monday, January 27th, at 6:30 p.m. at ...

The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in ...

Educators question whether the rapid shift toward more technology has benefited learning. ‘I really lose my focus.’ ...

CHICO — The biggest lesson in “Peter Pan Jr.” is that people should think positively.